07:00 , Aug 26, 2010 |  BC Innovations  |  Cover Story

The root of prostate cancer

A lack of useful prostate cancer models has limited research and identification of new treatments for the disease. Now, researchers at the University of California, Los Angeles have identified prostatic basal cells as the originators...
07:00 , Jul 10, 2006 |  BioCentury  |  Strategy

Diagnostic precision

By identifying real markets and focusing on consumer needs, the new generation of diagnostic companies has shaken off the sector's musty high volume, low value image. Using cutting edge technology to develop products that are...
08:00 , Jan 10, 2005 |  BC Week In Review  |  Company News

Corixa, Gen-Probe deal

CRXA granted GPRO rights to IP covering genetic sequences for about 50 markers of prostate, ovarian, cervical, kidney, lung and colon cancers. GPRO will use the markers, which include AMACR for prostate and colon cancers,...
08:00 , Jan 5, 2005 |  BC Extra  |  Company News

Gen-Probe, Corixa marker deal

CRXA granted GPRO rights to IP covering genetic sequences for about 50 markers of prostate, ovarian, cervical, kidney, lung and colon cancers. GPRO will use the markers, which include AMACR for prostate and colon cancers,...